ATE483019T1 - Aus einem neuroblastom in stufe 4s isoliertenukleinsäuren - Google Patents

Aus einem neuroblastom in stufe 4s isoliertenukleinsäuren

Info

Publication number
ATE483019T1
ATE483019T1 AT03770029T AT03770029T ATE483019T1 AT E483019 T1 ATE483019 T1 AT E483019T1 AT 03770029 T AT03770029 T AT 03770029T AT 03770029 T AT03770029 T AT 03770029T AT E483019 T1 ATE483019 T1 AT E483019T1
Authority
AT
Austria
Prior art keywords
neuroblastoma
nucleic acid
stage
tenucleic
acids isolated
Prior art date
Application number
AT03770029T
Other languages
English (en)
Inventor
Akira Nakagawara
Miki Ohira
Original Assignee
Hisamitsu Pharmaceutical Co
Chiba Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co, Chiba Prefecture filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE483019T1 publication Critical patent/ATE483019T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Image Processing (AREA)
AT03770029T 2002-10-30 2003-10-30 Aus einem neuroblastom in stufe 4s isoliertenukleinsäuren ATE483019T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002316586A JP4122205B2 (ja) 2002-10-30 2002-10-30 4s期神経芽細胞腫から単離された核酸
PCT/JP2003/013932 WO2004039975A1 (ja) 2002-10-30 2003-10-30 4s期神経芽細胞腫から単離された核酸

Publications (1)

Publication Number Publication Date
ATE483019T1 true ATE483019T1 (de) 2010-10-15

Family

ID=32211688

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03770029T ATE483019T1 (de) 2002-10-30 2003-10-30 Aus einem neuroblastom in stufe 4s isoliertenukleinsäuren

Country Status (6)

Country Link
US (1) US7429451B2 (de)
EP (1) EP1580265B1 (de)
JP (1) JP4122205B2 (de)
AT (1) ATE483019T1 (de)
DE (1) DE60334408D1 (de)
WO (1) WO2004039975A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004111274A1 (en) * 2003-06-10 2004-12-23 bioMérieux B.V. Nucleic acid sequences that can be used as primers and probes in the amplification and detection of sars coronavirus
US7601532B2 (en) 2003-09-25 2009-10-13 Hisamitsu Pharmaceutical Co., Inc. Microarray for predicting the prognosis of neuroblastoma and method for predicting the prognosis of neuroblastoma
EP1829967A4 (de) * 2004-12-03 2008-04-23 Aichi Prefecture Verfahren zur diagnose von malignem lymphom und abschätzung der prognose davon
GB0606954D0 (en) * 2006-04-06 2006-05-17 Randox Lab Ltd Method
JP2008029296A (ja) * 2006-07-31 2008-02-14 Hisamitsu Pharmaceut Co Inc 神経芽種の治療薬及びそのスクリーニング方法、並びに、神経芽種の予後の判定方法
US9115404B2 (en) 2009-06-19 2015-08-25 Max-Delbrück-Centrum Für Molekulare Medizin Berlin-Buch Polynucleotides for medical use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3605901A (en) 2000-03-07 2001-09-17 Chiba Prefecture Nucleic acid sequences showing enhanced expression in benign neuroblastoma compared with acritical human neuroblastoma
JP2001245671A (ja) 2000-03-07 2001-09-11 Chiba Prefecture ヒト神経芽細胞腫においてクローニングされた新規遺伝子及び新規遺伝子の断片
USH2191H1 (en) * 2000-10-24 2007-06-05 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome

Also Published As

Publication number Publication date
DE60334408D1 (de) 2010-11-11
WO2004039975A1 (ja) 2004-05-13
JP2004147563A (ja) 2004-05-27
US20070281296A1 (en) 2007-12-06
EP1580265A1 (de) 2005-09-28
JP4122205B2 (ja) 2008-07-23
EP1580265B1 (de) 2010-09-29
US7429451B2 (en) 2008-09-30
EP1580265A4 (de) 2006-08-30

Similar Documents

Publication Publication Date Title
WO2002068579A3 (en) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
WO2011096926A1 (en) Methods for preparing sequencing libraries
WO2000046407A3 (en) Methods of utilizing the tt virus
SE0301951D0 (sv) New method
WO2003027328A3 (en) Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid
JP2004528810A5 (de)
JP2006506979A5 (de)
WO2004044163A3 (en) Methods for identifying risk of melanoma and treatments thereof
Steinau et al. Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome
WO2005054516A3 (en) Peptide nucleic acid probes for analysis of certain staphylococcus species
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
DE60334408D1 (de) Nsäuren
ATE419533T1 (de) Verfahren/präparat zur erkennung von pankreaskrebs
EP1132483A3 (de) Methode zur Diagnose von Schizophrenie unter Verwendung objektiver Indizes
WO2002027036A3 (en) Probes, probe sets, methods and kits pertaining to the detection, identification and/or enumeration of bacteria
ATE433463T1 (de) Monospezifische antikörper gegen fibrinogen und fibrinopeptide b
EP1683862A4 (de) Mikroarray zur beurteilung der neuroblastomprognose und verfahren zur beurteilung der neuroblastomprognose
MXPA02009791A (es) El gen de alta masa osea de 11q13.3.
ATE315107T1 (de) Verfahren und kit zur früherkennung von krebs
EP1964921A3 (de) Das Gen für hohe Knochenmasse 11q13.3
CN104250649B (zh) 皮肤角化‑少毛‑白甲综合征新的致病基因及其编码蛋白质和应用
ATE478147T1 (de) Aus einem neuroblastom isolierte nukleinsäuren
WO2005049791A3 (en) Identification of reagents for the diagnosis and study of francisella
ATE440968T1 (de) Verfahren zur diagnostizierung von aspirinunverträglichkeit
DE60235568D1 (de) Diagnoseverfahren für krebs, das durch den nachweis der deletion des g-csf-exons 3 gekennzeichnet ist

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties